QuidelOrtho (QDEL) Other Non-Current Liabilities (2022 - 2026)
QuidelOrtho's (QDEL) quarterly Other Non-Current Liabilities came in at $112.4 million in Q1 2026, up 61.03% year-on-year from $69.8 million in Q1 2025, and down 32.45% quarter-over-quarter from $166.4 million in Q4 2025.
QuidelOrtho (QDEL) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
QuidelOrtho has disclosed Other Non-Current Liabilities across 5 years of filings, most recently posting $112.4 million for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $112.4 million, up 61.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $112.4 million (up 61.03% YoY), and the FY2025 annual result was $166.4 million, up 200.9% from the prior year.
- Other Non-Current Liabilities came in at $112.4 million for Q1 2026 at QuidelOrtho, down from $166.4 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $166.4 million in Q4 2025 to a low of $48.5 million in Q1 2022.
- The 5-year median for Other Non-Current Liabilities is $83.8 million (2023), against an average of $92.2 million.
- Across the five-year window, Other Non-Current Liabilities plunged 39.33% in 2024 and surged 200.9% in 2025, its largest moves.
- QuidelOrtho's Other Non-Current Liabilities stood at $86.6 million in 2022, then retreated by 3.46% to $83.6 million in 2023, then plunged by 33.85% to $55.3 million in 2024, then soared by 200.9% to $166.4 million in 2025, then plunged by 32.45% to $112.4 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $112.4 million (Q1 2026), $166.4 million (Q4 2025), and $138.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | QuidelOrtho | 934.34 Mn | 793.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 112.40 Mn |
| Dec 28, 2025 | 166.40 Mn |
| Sep 28, 2025 | 138.70 Mn |
| Jun 29, 2025 | 133.00 Mn |
| Mar 30, 2025 | 69.80 Mn |
| Dec 29, 2024 | 55.30 Mn |
| Sep 29, 2024 | 119.30 Mn |
| Jun 30, 2024 | 70.50 Mn |
| Mar 31, 2024 | 67.40 Mn |
| Dec 31, 2023 | 83.60 Mn |
| Oct 1, 2023 | 65.40 Mn |
| Jul 2, 2023 | 68.50 Mn |
| Apr 2, 2023 | 111.10 Mn |
| Jan 1, 2023 | 83.80 Mn |
| Oct 2, 2022 | 86.60 Mn |
| Jul 3, 2022 | 87.30 Mn |
| Jan 2, 2022 | 48.50 Mn |